Compounds > 9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene
Page last updated: 2024-11-13

9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene: RN given refers to cpd with unspecified isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91016426
MeSH IDM0080607

Synonyms (19)

Synonym
brn 4192582
7,8-dihydrobenzo(a)pyrene-9,10-epoxide
benzo(a)pyrene-9,10-epoxyide, 7,8,9,10-tetrahydro-
benzo(a)pyrene, 7,8,9,10-tetrahydro-9,10-epoxy-
7,8-dihydrobenzo(a)pyrene 9,10-epoxide
benzo(a)pyrene, 9,10-epoxy-7,8,9,10-tetrahydro-
9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene
benzo(a)pyrene-9,10-epoxide, 7,8,9,10-tetrahydro-
ccris 969
36504-68-4
5-17-02-00509 (beilstein handbook reference)
6k8cpv7b8k ,
unii-6k8cpv7b8k
benzo(10,11)chryseno(3,4-b)oxirene, 7,8,8a,9a-tetrahydro-
7,8,8a,9a-tetrahydrobenzo(10,11)chryseno(3,4-b)oxirene
7,8-dihydrobenzo(a)pyrene-9,10-oxide, (+/-)-
(9s,10r)-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene
7,8-dihydrobenzo[a]pyrene 9,10-epoxide
Q27265040
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
benzo(a)pyrene 7,8-dihydrodiol
benzo(a)pyrene 7,8-dihydrodiol: RN given refers to cpd without isomeric designation		1.9510pyrenes
7,8-dihydrobenzo(a)pyrene
7,8-dihydrobenzo(a)pyrene: structure given in first source		2.3620
6-hydroxybenzo(a)pyrene
6-hydroxybenzo(a)pyrene: RN given refers to parent cpd; structure in first source		1.9510ortho- and peri-fused polycyclic arene
benzo(a)pyrene 7,8-oxide
benzo(a)pyrene 7,8-oxide: RN given refers to cpd without isomeric designation; structure given in first source		1.9510pyrenes
benzo(a)pyrene 4,5-epoxide
benzo(a)pyrene 4,5-epoxide: RN given refers to cpd with unspecifiedisomeric designation		1.9510carbopolycyclic compound
7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide: 7,8,8a,9a-Tetrahydrobenzo(10,11)chryseno (3,4-b)oxirene-7,8-diol. A benzopyrene derivative with carcinogenic and mutagenic activity.		1.9510epoxideintercalator
2-hydroxybenzo(a)pyrene
2-hydroxybenzo(a)pyrene: RN given refers to parent cpd; structure in first source		1.9510ortho- and peri-fused polycyclic arene
hydroxyl radical
Hydroxyl Radical: The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.		2.0110oxygen hydride;
oxygen radical;
reactive oxygen species
oligonucleotides
[no description available]		2.0110
deoxyguanosine
[no description available]		1.9510purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
guanosine
ribonucleoside : Any nucleoside where the sugar component is D-ribose.		1.9610guanosines;
purines D-ribonucleoside		fundamental metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
EHS Tumor
[description not available]		01.9510
Fibrosarcoma
A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)		01.9510
Kaposi Disease
[description not available]		01.9510
Xeroderma Pigmentosum
A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.		01.9510
Experimental Hepatoma
[description not available]		01.9710
Condition, Preneoplastic
[description not available]		01.9710
Precancerous Conditions
Pathological conditions that tend eventually to become malignant.		01.9710